Increased plasma markers of inflammation and endothelial dysfunction in patients with different degree of chronic heart failure (CHF)

被引:0
作者
Radovanovic, Slavica [1 ]
Savic-Radojevic, Ana [2 ]
Simic, Dragan [3 ]
Krotin, Mirjana [1 ]
Djokovic, Aleksandra [1 ]
Ninkovic, Nebojsa [1 ]
Zdravkovic, Marija [1 ]
Saric, Jelena [1 ]
Zivanovic, Irena [1 ]
Simic, Tatjana [2 ]
机构
[1] Univ Hosp Bezanijska Kosa, Belgrade, Serbia
[2] Univ Sch Med, Inst Biochem, Belgrade, Serbia
[3] Belgrade Med Sch, Clin Cardiol, Belgrade, Serbia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AP039
引用
收藏
页码:E750 / E750
页数:1
相关论文
共 50 条
[21]   Dynamics of laboratory endothelial dysfunction markers in patients with acute decompensated chronic heart failure, treated with anticoagulants [J].
Shevchenko, I. Irina ;
Shavarov, A. A. ;
Kiyakbayev, G. K. ;
Moiseev, V. S. .
EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 :125-125
[22]   Physical training reduces peripheral inflammatory markers associated with endothelial dysfunction in patients with chronic heart failure [J].
Adamopoulos, S ;
Parissis, J ;
Kroupis, C ;
Georgiadis, M ;
Karatzas, D ;
Karavolias, GK ;
Koniavitou, K ;
Coats, AJS ;
Kremastinos, DTH .
EUROPEAN HEART JOURNAL, 2000, 21 :259-259
[23]   The features of cardiohemodynamic parameters, markers of kidney dysfunction and immune inflammation in patients with chronic heart failure and chronic kidney disease [J].
Mykhailova, I. ;
Lapshina, L. ;
Tytova, G. ;
Kravchyn, P. ;
Zolotaikina, V. .
EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 :S302-S303
[24]   EFFECTS OF SIMVASTATIN ON MARKERS OF INFLAMMATION, ENDOTHELIAL DYSFUNCTION AND APOPTOSIS IN CHRONIC HEMODIALYSIS PATIENTS [J].
Kirmizis, D. ;
Papagianni, A. ;
Belechri, A-M ;
Efstratiadis, G. ;
Alexopoulos, E. ;
Memmos, D. .
ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
[25]   Markers of renal dysfunction in chronic heart failure [J].
Matskevich, S. A. ;
Atroschenko, E. S. ;
Barbuk, O. A. ;
Belskaya, M. I. .
EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 :367-368
[26]   Growth hormone corrects endothelial dysfunction in patients with chronic heart failure [J].
Napoli, R ;
Guardasole, V ;
Matarazzo, M ;
Palmieri, EA ;
Oliviero, U ;
Fazio, S ;
Sacca, L .
CIRCULATION, 2001, 104 (17) :366-367
[27]   Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure [J].
Hornig, B ;
Arakawa, N ;
Drexler, H .
EUROPEAN HEART JOURNAL, 1998, 19 :G48-G53
[28]   Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure [J].
Katz, SD ;
Hryniewicz, K ;
Hriljac, I ;
Balidemaj, K ;
Dimayuga, C ;
Hudaihed, A ;
Yasskiy, A .
CIRCULATION, 2005, 111 (03) :310-314
[29]   Evaluation of endothelial dysfunction in patients with arterial hypertension and chronic heart failure [J].
Sapatyi, AAndriy ;
Kupnovytska, I. G. ;
Belegai, R. I. .
EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 :173-173
[30]   Correlation of selected chronic inflammation and endothelial dysfunction markers with different stages of chronic kidney disease (CKD) [J].
Pawlaczyk, Krzysztof ;
Krupa, Dariusz ;
Simachowicz, Agnieszka ;
Oko, Andrzej ;
Lindholm, Bengt ;
Czekalski, Stanislaw .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 :389-389